Physician profile
Peter Lee Mayer
NPI 1881774206
$2,146.67
in general payments reported to CMS, 2019-2025
17 companies · $434 in 2025
The $434 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $36.70 · 2021: $64.54 · 2022: $102 · 2023: $175 · 2024: $634 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $572.00 | 2019 | |
| Medtronic, INC. | $396.18 | 2023-2025 | Catalyft Pl Expandable Interbody System, Stealthstation S8 Platform, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Orthofix Medical, INC. | $244.57 | 2022-2025 | Spinal-Stim, Stim On Track, Spinal-Stim |
| Gt Medical Technologies, INC | $177.50 | 2025 | Gammatile |
| Stryker Corporation | $131.33 | 2019-2025 | Allograft |
| Baxter Healthcare | $122.06 | 2024 | Starling System |
| Globus Medical, INC. | $100.00 | 2019 | |
| Brainlab, INC. | $97.13 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Nico Corporation | $88.36 | 2024 | |
| Smith+Nephew, INC. | $41.57 | 2024-2025 | Pico, Renasys Touch |
| Boston Scientific Corporation | $41.39 | 2022 | |
| Depuy Synthes Sales INC. | $38.29 | 2022 | |
| Scilex Pharmaceuticals INC. | $21.39 | 2024 | |
| Checkpoint Surgical, INC | $20.87 | 2025 | Checkpoint Stimulators |
| Spinal Elements, INC. | $19.98 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.08 | 2023 | Proclaim |
| Portola Pharmaceuticals, LLC | $15.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.